Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 430 (LINC00430) is a long non-coding RNA (lncRNA) gene located on chromosome 13 (hg38: 86,909,524-86,912,443)[5][9]. It does not encode a protein, and its sequence is annotated in reference gene databases and the HUGO Gene Nomenclature Committee as an approved non-coding RNA gene[1][9]. LINC00430 is also referred to as TCONS_00021581. The biological role of LINC00430 has not been precisely defined in current curated literature, and there is no strong evidence for its involvement as a direct therapeutic target, disease biomarker, or in drug interaction pathways[7][9][13]. While many lncRNAs are implicated in transcriptional and epigenetic regulation, no specific regulatory or disease-modulatory function is currently reported for LINC00430 in major databases as of 2024.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 430 (LINC00430).